Daily Media Digest July 13, 2018
Health Canada Approves Tagrisso® (osimertinib) as First-line Treatment for EGFR-Mutated Non-Small Cell Lung Cancer Canada NewsWire (press release) “MISSISSAUGA, ON, July 12, 2018 /CNW/ – AstraZeneca Canada today announced that Health Canada has approved Tagrisso® […]